The Regenerative Medicine Industry Interface (RMI2)

BioMedVic is pleased to be a founding partner of the Regenerative Medicine Industry Interface (RMI2).

This consortium brings together

  • Basic and applied research capability (Australian Regenerative Medicine Institute at Monash University, CSIRO, The University of Melbourne) together with industry and networking associations (BioMelbourne Network, BioMedVic, AusBiotech) and an international technology transfer hub in partnership with the regenerative medicine industry.
  • Access to high calibre research students through the Monash University Graduate Research Industry Program (GRIP) for PhD students and Monash University Business School for Executive MBA students.
  • Commercialisation expertise and international access through a satellite hub of the Centre for Commercialisation of Regenerative Medicine (CCRM).

RMI2 is an initiative of the Australian Regenerative Medicine Institute (ARMI) in partnership with Monash and Melbourne Universities, the BioMelbourne Network and Industry Partners, to progress opportunities in Australia through research excellence, highly skilled workforce and a globally connected platform for commercialisation and investment.

RMI2 is offering two industry-led PhD programs for potential students interested in working in regenerative medicine. See the ARMI website for more information.

BioMedVic March Newslettter

Government internships for researchers, UROP hits new record & more!
Opportunity | Researcher in residence
Have your say | BioMedVic Submission to 2030 Strategic Plan Consultation
Savings for Members | Discount on NatureJobs Ads
Student interest for UROP hits new record in 2017!
Upcoming events & more | Read more

BioMedVic Advocacy Hits the Ground Running in 2017

hengelhardt_brv_board-meeting_17

As for many Australian organisations, December-January was a quieter period for BioMedVic. But our advocacy on behalf of Members continues.

Victorian Parliament resumed last week and most of our Members are ‘back in town’. Amanda Caples and I are in the diary to catch up about what’s happening in DEDJTR and at BioMedVic, to hear what her plans are as Lead Scientist for the state and in which areas BioMedVic may be of assistance. Among the topics I will raise when I meet with Linda Christine, Director Innovation, Industry and International Health in DHHS, is the future of the Operational Infrastructure Support Program that provides funding for indirect research costs to eligible independent medical research institutes in Victoria. Continue reading

It’s Our Time to Shine

biomed_research_vic_5069It’s time to celebrate – Victoria holds rank as Australia’s capital of health and biomedical research. But how will the sector evolve in 2017?

We recently learned that Victorian health and medical researchers, a majority from BioMedVic member organisations, secured over 40% of the NHMRC funding pie – and we celebrate this wonderful news wholeheartedly. Part of our success can be attributed to our well-established ability to work collaboratively in Victoria. One exemplar of this claim was the recent recognition of a longstanding collaboration between Jim McCluskey from the University of Melbourne and Jamie Rossjohn from Monash University. An international recognition was the Nature Index ranking Melbourne as one of the 10 centres around the world with the most intra-city research partnerships in 2015.

But we mustn’t rest on our laurels.

While it’s no secret that Melbourne thrives on collaborations and is inspired by innovation, we need to share not only our research infrastructure and skills, but our voice – particularly to government. A collaborative culture is needed to tackle the big challenges head-on, and to ensure our sector shines brightly and to its full potential. Because while we hear of grand political gestures, we need our combined expertise to come together to future-proof these plans.

BioMedVic has strong ties with the State Government which we use to advocate on behalf of our Members. We offer leadership in the sector and a robust connection to government decision-makers which withstands the pressures of short-term political cycles.

I want to remind Members that a collective voice is more powerful than that of any single member. This year, we saw just how powerful this voice can be.

In the run-up to the last state election, we met with policy makers from both parties, advocating for a long-term, well-coordinated Victorian innovation plan and suggested methods for establishing state-wide priorities and governance arrangements.

This year, we saw our advocacy platforms paying off with BioMedVic’s vision that Victoria become a global leader in health and medical innovation featuring in the Victorian Health and Medical Research Strategy 2016-2020. This strategy responded to many of the recommendations submitted by BioMedVic, and we are proud to see a collective vision of our Members reflected.

Like the Western Bulldogs, BioMedVic is going for back-to-back performance in 2017.

I sincerely thank you for your support this year and wish you all the best for the festive season, and hope that you return refreshed and inspired for the New Year.

 Jan Tennent

Strengthening Victoria’s relationships with Osaka

BioMedVic CEO Prof Jan Tennent bolstered international bridges for clinical research and trials this month, as she hosted a delegation from Osaka to discuss professional exchange opportunities abroad for Victoria’s clinicians and scientists. Continue reading

Victoria’s HMR sector set to grow

We’re excited to announce that Dr George Morstyn, Chairman of Biomedical Research Victoria, has been selected for a new panel established by the Victorian Government to advise on how to attract more investment and jobs to Victoria.

With the aim to drive leadership and excellence in Victorian health and medical research, the Science, Medical Research and Technology Panel will provide advice on attracting funding for medical research, protecting intellectual property, and the translation and commercialisation of research. Continue reading

BioMedVic – Uniting Victorian Research

At the risk of mixing metaphors, there’s never been a better time for a grand coalition of health and medical research organisations such as is represented by Biomedical Research Victoria. Whether it forays into deep space or the human genome, history has shown that a united front will prevail.

Notwithstanding that the component parts will continue to pursue their own agenda, none can claim a ‘mortgage’ on the source of innovation or to have the exclusive ear of government. Some matters are best addressed, or have a better chance of being resolved, through a collaborative and collegial approach built on mutual respect and recognition of the synergy that can be achieved when all interested parties contribute.

Continue reading

How to Split the Pie

coinsBring industry expertise to academia – this was the message I brought to Ian Frazer when he was in Melbourne recently with other members of the Australian Medical Research Advisory Board for a public consultation on the MRFF.

I recommended a portion of the Fund would be well spent on initiatives to embed colleagues with experience and a successful track record gained in industry into research. This suggestion was made rather than, or at least in addition to, the reverse – a call for increasing numbers of researchers to spend time in industry learning the ropes of commercialisation, which while admirable may take some considerable time to yield the results we hope for. The proposal was not surprising given my own experience and that of several BioMedVic Directors who can all attest to the two-way impact of building bridges between industry and academia, something BioMedVic has encouraged for some time. Continue reading

BioMedVic August News

  • Farewell and Profound Thanks to Professor Ian Gust
  • Welcome to new Chair, Dr George Morstyn
  • BioMedVic – Celebrating 15 Years of Advocacy
  • UROP Gearing up for Round Two

Welcome to New Chair Dr George Morstyn

George-Morstyn2

This month, we appointed Dr George Morstyn as Biomedical Research Victoria’s new Board Chair.

Continue reading